Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
1.820
+0.040 (2.25%)
Jul 2, 2025, 4:00 PM - Market closed
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $4.84 million as of July 3, 2025. Its market cap has increased by 84.45% in one year.
Market Cap
4.84M
Enterprise Value
4.29M
1-Year Change
84.45%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $4.84M, a decrease of -88.24%. That is a compound annual growth rate of -46.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 4.74M | 20.65% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.81B |
| Johnson & Johnson | 367.53B |
| AbbVie | 327.88B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 283.00B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.64B |
| AstraZeneca | 215.00B |